Moxibustion for Fetus in Breech Presentation

University Hospitals (UH)

Status and phase: Completed; Phase 3

Conditions: Breech Presentation

Treatments: Procedure: Moxibustion of the BL67 acupoint

Study type: Interventional

Funder types: Other

Identifiers

NCT00890474

Moxibustion_siege

Details and patient eligibility

About

Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting. The hypothesis is that moxibustion increase the likelihood of cephalic version.

Design: Randomised controlled trial Setting: University hospital. Population: A total of 212 consenting women between 34 and 36 weeks of gestation with a single fetus in breech presentation will be randomised to moxibustion (n=106) or expectant management (n=106).

Main Outcome Measure: Cephalic presentation at delivery or before external cephalic version.

Enrollment: 212 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Breech presentation
• 34 to 36 weeks of gestation
• Single fetus

Exclusion criteria

• Uterine malformation
• Placenta praevia
• Transverse lie

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

212 participants in 2 patient groups

Moxibustion

Experimental group

Treatment:

Procedure: Moxibustion of the BL67 acupoint

Control

No Intervention group